Biotech Fluidics announce the SmartSaver solvent recycling unit - designed to recover up to 90% of your mobile phase by redirection of the pure solvent to the solvent reservoir during isocratic HPLC.

Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.

Member-led steering committees composed of global pharma and tech representatives will develop new project ideas to drive industry change.

The mechanism targets both integrated virus and cccDNA; expected to begin clinical testing by end of 2024. Preclinical program data to be presented at the 2023 Hep DART Conference .

TESTA Analytical announce new 21CFR Part 11 compliance software for use with its popular family of NanoBrook particle sizing and zeta potential instrumentation.

A multitude of resistance genes in crop genomes could be brought back to life.

New NGS assay delivers exceptional coverage, providing a rapid and highly sensitive means of investigating MRD in AML samples.

Visitors to London Vet Show can see how new reagent pack sizes make rapid point-of-care PCR more accessible.

Xsphera Biosciences, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I, a Seoul-based pioneer in immune-oncology therapeutics.

Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.